Regulus Therapeutics Inc. SC 13D and SC 13D/A reports

Location
4224 Campus Point Court, Suite 210, San Diego, California
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
6/25/2024, 01:20 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES V, LLC - REGULUS THERAPEUTICS -- SCHEDULE 13D/A(#4) Mar 18, 2024
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES V, LLC - REGULUS THERAPEUTICS -- SCHEDULE 13D/A(#3) May 12, 2023
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES FUND V, LLC - REGULUS THERAPEUTICS -- SCHEDULE 13D/A Dec 9, 2021
SC 13D/A Report SCHEDULE 13D/A, AMENDMENT #1 Jan 3, 2020
SC 13D Report SCHEDULE 13D May 17, 2019
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES FUND V, LLC - REGULUS THERAPEUTICS INC. 13DA(#1) May 15, 2019
SC 13D Report GROWTH EQUITY OPPORTUNITIES FUND V, LLC - REGULUS 13D Aug 2, 2017
SC 13D/A Report SC 13D/A Jul 31, 2015
SC 13D/A Report SC 13D/A Nov 6, 2014
SC 13D Report SC 13D Oct 19, 2012